Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.

Sanders ME, Taylor S, Tullos N, Norcross EW, Moore QC 3rd, Thompson H, King LB, Marquart ME.

BMC Ophthalmol. 2013 Mar 11;13:8. doi: 10.1186/1471-2415-13-8.

2.

Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells.

Norcross EW, Sanders ME, Moore QC 3rd, Marquart ME.

J Bacteriol Parasitol. 2011;2(2):108.

3.

Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Norcross EW, Sanders ME, Moore QC 3rd, Taylor SD, Tullos NA, Caston RR, Dixon SN, Nahm MH, Burton RL, Thompson H, McDaniel LS, Marquart ME.

Invest Ophthalmol Vis Sci. 2011 Nov 29;52(12):9232-43. doi: 10.1167/iovs.10-6968.

4.

The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis.

Sanders ME, Norcross EW, Robertson ZM, Moore QC 3rd, Fratkin J, Marquart ME.

Invest Ophthalmol Vis Sci. 2011 Feb 22;52(2):865-72. doi: 10.1167/iovs.10-5513. Print 2011 Feb.

5.

Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Sanders ME, Norcross EW, Moore QC 3rd, Fratkin J, Thompson H, Marquart ME.

J Ocul Pharmacol Ther. 2010 Dec;26(6):571-7. doi: 10.1089/jop.2010.0077. Epub 2010 Oct 29.

6.

Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.

Sanders ME, Moore QC 3rd, Norcross EW, Sanfilippo CM, Hesje CK, Shafiee A, Marquart ME.

Cornea. 2011 Jan;30(1):83-90. doi: 10.1097/ICO.0b013e3181e2f0f3.

PMID:
20847656
7.

Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.

Sanders ME, Moore QC 3rd, Norcross EW, Shafiee A, Marquart ME.

J Ocul Pharmacol Ther. 2010 Apr;26(2):193-8. doi: 10.1089/jop.2009.0121.

PMID:
20334537
8.

Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.

Sanders ME, Norcross EW, Moore QC 3rd, Shafiee A, Marquart ME.

Cornea. 2009 Oct;28(9):1055-60. doi: 10.1097/ICO.0b013e31819e34cb.

PMID:
19724203
9.

A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model.

Sanders ME, Norcross EW, Moore QC, Onwubiko C, King LB, Fratkin J, Marquart ME.

Clin Ophthalmol. 2008 Dec;2(4):793-800.

10.

Development of a Streptococcus pneumoniae keratitis model in mice.

Moore QC 3rd, McCormick CC, Norcross EW, Onwubiko C, Sanders ME, Fratkin J, McDaniel LS, O'Callaghan RJ, Marquart ME.

Ophthalmic Res. 2009;42(3):141-6. doi: 10.1159/000229028. Epub 2009 Jul 23.

11.

Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum.

Green SN, Sanders M, Moore QC 3rd, Norcross EW, Monds KS, Caballero AR, McDaniel LS, Robinson SA, Onwubiko C, O'Callaghan RJ, Marquart ME.

Invest Ophthalmol Vis Sci. 2008 Jan;49(1):290-4. doi: 10.1167/iovs.07-0492.

12.

Peritoneal challenge modulates expression of pneumococcal surface protein C during bacteremia in mice.

Quin LR, Moore QC 3rd, Thornton JA, McDaniel LS.

Infect Immun. 2008 Mar;76(3):1122-7. Epub 2007 Dec 26.

13.

Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo.

Quin LR, Onwubiko C, Moore QC, Mills MF, McDaniel LS, Carmicle S.

Infect Immun. 2007 Aug;75(8):4082-7. Epub 2007 Jun 11.

14.

Immunization with PspA incorporated into a poly(ethylene oxide) matrix elicits protective immunity against Streptococcus pneumoniae.

Moore QC 3rd, Johnson L, Repka M, McDaniel LS.

Clin Vaccine Immunol. 2007 Jun;14(6):789-91. Epub 2007 Apr 25.

15.

Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice.

Quin LR, Moore QC 3rd, McDaniel LS.

Infect Immun. 2007 Apr;75(4):2067-70. Epub 2007 Jan 12.

16.

Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.

Moore QC, Bosarge JR, Quin LR, McDaniel LS.

Vaccine. 2006 Jul 17;24(29-30):5755-61. Epub 2006 May 4.

PMID:
16759765

Supplemental Content

Loading ...
Support Center